Publications by authors named "Hai-Bo Zhuo"
Article Synopsis
- The study investigated the effectiveness and safety of three antiviral treatments (azvudine, nirmatrelvir/ritonavir, and molnupiravir) for adults with mild-to-moderate COVID-19 at a hospital in China.
- It included 157 patients divided into the three treatment groups, and measured the time it took for patients to achieve nucleic acid negative conversion (NANC).
- Results showed no significant differences in conversion times, hospital stays, or adverse effects among the treatments, indicating azvudine could be as effective as the others in treating mild-to-moderate COVID-19.
